Latest IR information
IR News
- 2026.05.18

- SymBio Establishes Stable Supply Framework for Ultra-High-Sensitive (Pico-Level) Immunochromatography System


- 2026.05.12

- CRADA with NIAID on BCV for Post-Transplant Lymphoproliferative Disorder (PTLD) Extended for Three Years — SymBio to Advance Development of Brincidofovir (BCV) for EBV-Associated Diseases —


- 2026.05.07

- Summary of Consolidated Financial Statements for the Three Months ended March 31, 2026 [Japanese GAAP]


- 2026.05.01

- Notice Regarding the Monthly Exercise Status of the 58th and 66th Stock Acquisition Rights (with Exercise Price Adjustment Clause) Issued through Third-Party Allotment


- 2026.04.22

- Brincidofovir Shows Efficacy in Preclinical Study of EBV-Associated Gastric Carcinoma Poster Presentation Accepted at the ASCO Annual Meeting 2026

